Cargando…

Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results

BACKGROUND: This study investigates the efficiency of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia (CAP) and assesses their long-term effects. METHODS: The study included 55 patients with non-severe CAP. Group 1 (control) received only standard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostinov, Mikhail P, Gainitdinova, Vilia V, Kazharova, Svetlana V, Vlasenko, Anna E, Polishchuk, Vflentina B, Mashilov, Kirill V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435266/ https://www.ncbi.nlm.nih.gov/pubmed/37602358 http://dx.doi.org/10.7573/dic.2022-10-5

Ejemplares similares

Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms
por: Kostinov, Mikhail, et al.
Publicado: (2023)

Nonspecific Regulation of the Number of Immunocompetent Cells Under the Influence of DT Toxoid in Children With Glomerulonephritis
por: Kostinov, Mikhail Petrovich, et al.
Publicado: (2021)

Gender Differences in the Level of Antibodies to Measles Virus in Adults
por: Kostinov, P. Mikhail, et al.
Publicado: (2021)

Vaccination Against Diphtheria and Tetanus as a Way to Activate Adaptive Immunity in Children with Solid Tumors
por: Kostinov, Mikhail Petrovich, et al.
Publicado: (2021)

Comparative Analysis of the Measles Antibody Levels in Healthy Medical Personnel of Maternity Ward and Women in Labor
por: Kostinov, Mikhail Petrovich, et al.
Publicado: (2021)

Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
por: Bhan, Urvashi, et al.
Publicado: (2015)

Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia
por: Esposito, Susanna, et al.
Publicado: (2015)

Is the role of rhinoviruses as causative agents of pediatric community-acquired pneumonia over-estimated?
por: Spichak, Tatyana V., et al.
Publicado: (2016)

Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
por: Gadsby, Naomi J., et al.
Publicado: (2016)

Immunomodulatory and Allergenic Properties of Antimicrobial Peptides
por: Guryanova, Svetlana V., et al.
Publicado: (2022)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2020)

Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review
por: Davis, Don, et al.
Publicado: (2023)

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency
por: Kostinov, Mikhail P., et al.
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Community-acquired pneumonia
por: Niederman, Michael S.
Publicado: (2010)

Community-Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2017)

Community‐Acquired Pneumonia
Publicado: (2007)

Community-acquired pneumonia
por: Prina, Elena, et al.
Publicado: (2015)

Community Acquired Pneumonia
por: Finch, Roger
Publicado: (1998)

What Parts of Reappraisal Make Us Feel Better? Dissociating the Generation of Reappraisals from Their Implementation
por: Waugh, Christian E., et al.
Publicado: (2022)

Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
por: Méndez, Raúl, et al.
Publicado: (2023)

Expression of Toll-like Receptors on the Immune Cells in Patients with Common Variable Immune Deficiency after Different Schemes of Influenza Vaccination
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2023)

Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia
por: Stankovic, Curt, et al.
Publicado: (2007)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Community-acquired pneumonia in children
por: Davies, H Dele
Publicado: (2003)

Epidemiology of community acquired pneumonia
por: Manikam, Logan, et al.
Publicado: (2012)

Community-Acquired Pneumonia in Childhood
por: Popovsky, Erica Y., et al.
Publicado: (2022)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Issues in Community-Acquired Pneumonia
por: Fong, I. W.
Publicado: (2020)

Etiology of Community-Acquired Pneumonia
por: Apisarnthanarak, Anucha, et al.
Publicado: (2005)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tbvhnnsiojcgn71f5kvpo2af04